About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
Press ReleaseCardiawave announces positive 6-month data from its Valvosoft Pivotal Study, presented at TCT Conference ! Oct 29, 2024 READ MORE
About UsArticle Le Figaro: “Les immenses promesses cliniques des ultrasons thérapeutiques” Oct 15, 2024 READ MORE
EventsPr Hélène Eltchaninoff presenting Cardiawave’s latest clinical studies at TCT 2024 in Washington ! Oct 7, 2024 READ MORE
EventsJournée Mondiale du Coeur: Pr Damien Metz considère la technologie Valvosoft® comme un complément potentiel aux moyens thérapeutiques existants Sep 30, 2024 READ MORE
EventsJournée Mondiale du Coeur: Pr Hélène Eltchaninoff soutient les nouvelles solutions thérapeutiques telles que Valvosoft® pour la prise charge de la sténose aortique Sep 30, 2024 READ MORE
EventsClara Magnier, PhD student, presenting at the ISTU 2024 conference in Taipei (Taiwan) ! Sep 19, 2024 READ MORE
About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
